🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fantastic visit this morning by Mayor Mendenhall (SLC) to Altitude Lab - we shared PEEL's approach of using nature and technology to make new medicines! Go elephants, trees, & baby proteins! Thank you, Mayor Mendenhall. Mayor Erin Mendenhall, Altitude Lab, BioHive, Peel Therapeutics, Inc., #elephants

NOW ONLINE | New study by Logan Spector, Aubrey K. Hubbard, et al Authors used data from the #Cancer #Incidence in Five Continents database to describe trends in #EwingSarcoma incidence across time, geographic regions & race/ethnicity Read it here! ➡️bit.ly/3wPlfsn University of Minnesota

Exciting news from Altitude Lab this morning! The investor coalition launches today, which includes $50 million in funding and continuous mentorship for biotech startups like Peel Therapeutics, Inc.. Can’t wait to meet our mentors! Learn more at altitudelab.org/news x.com/AltitudeLab/st…

Peel Therapeutics, Inc. isn't just creating breakthrough cancer therapies, they constantly connect their peers to experts at Huntsman Cancer Institute and uofu and help other resident #founders think through scientific and business challenges. See how we build community: altitudelab.org

Researchers identify a new poor prognostic marker in childhood leukemia. Across 6 cohorts of 1,310 pediatric B-ALL patients, combined focal 22q11.22 deletion + IKZF1 alteration predicts 43% event-free survival (EFS) vs 69% EFS for IKZF1 alteration alone ja.ma/37Ussgj

Excited to read this article in Utah Business Magazine! Our Peel team continues around the clock to make the evolutionary revolutionary! #PeelTherapeutics, #EvolutionaryMedicine, #Elephants utahbusiness.com/peel-therapeut…

Today we announced the initiation of our first-in-human clinical study of PEEL-224 in patients with advanced solid tumors, following the recent acceptance of our Investigational New Drug Application by the U.S. Food and Drug Administration. Read more here: peeltx.com/news/peel-ther…

Thrilled that Peel Therapeutics won the 2023 People's Choice Award tonight at Altitude's Demo Day (altitudelab.org/demo), especially since the crowd also included high school students - some of the toughest critics! Big thanks to Peel team and Altitude Lab! #BioHive, #BioUtah

It was an amazing adventure to deliver the Darwin Lecture in November at ICR in London! Thank you to my friend, mentor, host, and fellow Darwin aficionado, Professor Sir Mel Greaves. #Darwin, #EvolutionaryMedicine, #icr, #peeltherapeutics icr.ac.uk/blogs/science-…

Amazing new paper about elephants and their cancer fighting p53 genes! Great example of how studying evolution gives new insights that could help future drug development. Elephants and their cancer resistance inspired the start of Peel Therapeutics! nature.com/articles/s4142…

Congratulations to Dr. Avi Schroeder on his election as Fellow of AIMBE. Way to go, Avi! linkedin.com/feed/update/ur…

Great article this week in BioWorld that describes Peel Therapeutics, Inc. and our best-in-class TOP1 inhibitor in Phase 1 clinical trial for advanced solid tumors. Peel Therapeutics, Inc. unlocks evolutionary biology to make new medicines for patients in need. bioworld.com/articles/70227…

Great new article today by Luisa Torres in Drug Discovery News about our Darwin Discovery Platform in Peel Therapeutics! drugdiscoverynews.com/from-wildlife-…

Fantastic article today in Drug Discovery News about our Darwin Discovery Platform, and how Peel Therapeutics, Inc. unlocks evolution for patients! Isn't evolution beautiful? drugdiscoverynews.com/from-wildlife-…

Excited to give closing talk this afternoon at the AACR WORKSHOP ON TRANSLATIONAL CANCER RESEARCH FOR BASIC SCIENTISTS. Thank you, AACR , for this opportunity. Go evolutionary medicine! Go Peel Therapeutics!

Excited for Children's Hospital of Philadelphia (CHOP) and their patients who now have access to PEEL-224 through a new CHOP-sponsored clinical trial. Amazing to reach this pediatric milestone in PEEL-224 development, a drug originally developed at CHOP. research.chop.edu/cornerstone-bl…

biohive.com/from-physician…

Thank you to BioHive for the great article highlighting Peel Therapeutics, Inc. and the team. Together we're introducing new medicines for cancer that are effective and safe for patients. biohive.com/from-physician…

Come join us at BIO International for our panel to discuss the newest approaches to cancer therapy, Tuesday, June 17, 1:45 PM in Boston.